Abstract:Hypoxia is a common characteristic of solid tumors. This important feature is associated with resistance to radio-chemotherapy, which results in poor prognosis and probability of tumor recurrence. Taking advantage of background-free NIR II fluorescence imaging and deeper-penetrating photoacoustic (PA) imaging, we developed a hypoxia-triggered and nitroreductase (NTR) enzyme-responsive single molecule probe for high-contrast NIR II/PA tumor imaging and hypoxia-activated photothermal therapy (PTT), which will overcome cellular resistance during hypoxia. Methods: The single molecule probe IR1048-MZ was synthesized by conjugating a nitro imidazole group as a specific hypoxia trigger with an IR-1048 dye as a NIR II/PA signal reporter. We investigated the NIR II fluorescence, NIR absorbance and photothermal effect in different hypoxia conditions in vitro, and performed NIR II/PA tumor imaging and hypoxia-activated photothermal therapy in mice. Results: This versatile molecular probe IR1048-MZ not only realized high-contrast tumor visualization with a clear boundary by NIR II fluorescence imaging, but also afforded deep-tissue penetration at the centimeter level by 3D PA imaging. Moreover, after being activated by NTR that is overexpressed in hypoxic tumors, the probe exhibited a significant photothermal effect for curative tumor ablation with no recurrence. Conclusions: We have developed the first hypoxia-triggered and NTR enzyme-responsive single molecule probe for high-contrast NIR II/PA tumor imaging and hypoxia-activated photothermal therapy. By tracing the activity of NTR, IR1048-MZ may be a promising contrast agent and theranostic formulation for other hypoxia-related diseases (such as cancer, inflammation, stroke, and cardiac ischemia).

Development of a Hypoxia-Activated Red-Emission Fluorescent Probe for in Vivo Tumor Microenvironment Imaging and Anti-Tumor Therapy

Fluorescent Probe for Hypoxia-triggered Imaging and Cancer Therapy

Hypoxia-responsive fluorescent nanoprobe for imaging and cancer therapy

A Bioluminescent Probe for Tumor Hypoxia Detection via CYP450 Reductase in Living Animals.

Hypoxia Imaging in Cells and Tumor Tissues Using a Highly Selective Fluorescent Nitroreductase Probe.

Hypoxia-triggered single molecule probe for high-contrast NIR II/PA tumor imaging and robust photothermal therapy

A Simple Aggregation-Induced Emission Nanoprobe With Deep Tumor Penetration For Hypoxia Detection And Imaging-Guided Surgery In Vivo

A near-infrared multifunctional fluorescent probe for hypoxia monitoring and tumor-targeted therapy

A Near-Infrared Phosphorescent Nanoprobe Enables Quantitative, Longitudinal Imaging of Tumor Hypoxia Dynamics During Radiotherapy.

Optical Monitoring and Treatment of Breast Cancer by a Tumor Hypoxia-Activated Multi-Functional Fluorescent Sensor

Afterglow/Fluorescence Dual-Emissive Ratiometric Oxygen Probe for Tumor Hypoxia Imaging

Hypoxia-Responsive Molecular Probe Lighted up by Peptide Self-Assembly for Cancer Cell Imaging

Positron Emission Tomography Imaging of Tumor Hypoxia

Progress in fluorescent probes for tumor hypoxia

Near-Infrared Fluorescent Probes for Hypoxia Detection via Joint Regulated Enzymes: Design, Synthesis, and Application in Living Cells and Mice.

A Novel Off-on Fluorescent Probe for Imaging of Hypoxia in Tumor Cell

Hypoxia-specific Ultrasensitive Detection of Tumours and Cancer Cells in Vivo.

Hypoxia-activated probe for NIR fluorescence and photoacoustic dual-mode tumor imaging

Quantitative hypoxia mapping using a self-calibrated activatable nanoprobe

A Nitroreductase Responsive and Photoactivated Fluorescent Probe for Dual-Controlled Tumor Hypoxia Imaging

A Probe for the Detection of Hypoxic Cancer Cells.